Cargando…

A Systematic Review and Network Meta-Analysis to Evaluate the Comparative Efficacy of Interventions for Unfit Patients with Chronic Lymphocytic Leukemia

INTRODUCTION: Rituximab plus fludarabine and cyclophosphamide (RFC) is the standard of care for fit patients with untreated chronic lymphocytic leukemia (CLL); however, its use is limited in ‘unfit’ (co-morbid and/or full-dose F-ineligible) patients due to its toxicity profile. We conducted a system...

Descripción completa

Detalles Bibliográficos
Autores principales:	Städler, Nicolas, Shang, Aijing, Bosch, Francesc, Briggs, Andrew, Goede, Valentin, Berthier, Aurelien, Renaudin, Corinne, Leblond, Veronique
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2016
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5055565/ https://www.ncbi.nlm.nih.gov/pubmed/27535291 http://dx.doi.org/10.1007/s12325-016-0398-2

Ejemplares similares

The Unfit
por: Sinclair, W. J. H.
Publicado: (1911)

The Unfit
Publicado: (1911)

Dose Intensive Rituximab and High-Dose Methylprednisolone in Elderly or Unfit Patients with Relapsed Chronic Lymphocytic Leukemia
por: Pileckyte, Regina, et al.
Publicado: (2019)

The Marriage of the Unfit
Publicado: (1898)

The Sterilsation of the Unfit
Publicado: (1913)

Sterilization of the Unfit
por: Bristowe, H. C.
Publicado: (1931)

National "Unfits"
Publicado: (1920)

Multiplication of the Unfit
Publicado: (1921)

Asexualization of the Unfit
Publicado: (1912)

The Marriage of the Unfit
por: Campbell, Harry
Publicado: (1898)

Sterilization of the Unfit
por: Bogart, G. Henri
Publicado: (1912)

Sterilizing the Unfit
por: Bogart, G. Henri
Publicado: (1912)

Sterilization of the Unfit
por: Bogart, G. Henri
Publicado: (1910)

Asexualization of the Unfit
Publicado: (1912)

Sterilizing the Unfit
por: Bogart, G. Henri
Publicado: (1913)

Therapeutic potential of new B cell-targeted agents in the treatment of elderly and unfit patients with chronic lymphocytic leukemia
por: Rai, Kanti R.
Publicado: (2015)

Treatment Options for Elderly/Unfit Patients with Chronic Lymphocytic Leukemia in the Era of Targeted Drugs: A Comprehensive Review
por: Fresa, Alberto, et al.
Publicado: (2021)

Feasibility and efficacy of addition of individualized-dose lenalidomide to chlorambucil and rituximab as first-line treatment in elderly and FCR-unfit patients with advanced chronic lymphocytic leukemia
por: Kater, Arnon P., et al.
Publicado: (2019)

Efficacy of Front-Line Ibrutinib and Rituximab Combination and the Impact of Treatment Discontinuation in Unfit Patients with Chronic Lymphocytic Leukemia: Results of the Gimema LLC1114 Study
por: Mauro, Francesca Romana, et al.
Publicado: (2021)

Urothelial carcinoma management in elderly or unfit patients()
por: Bellmunt, Joaquim, et al.
Publicado: (2016)

Obinutuzumab in chronic lymphocytic leukemia: design, development and place in therapy
por: Al-Sawaf, Othman, et al.
Publicado: (2017)

Making the Unfit into Serviceable Recruits
Publicado: (1916)

The Survival of the Unfit in Human Dentition
por: Parker, J. C.
Publicado: (1889)

Safeguarding Society from the Unfit
por: Cooke, A. B.
Publicado: (1911)

Efficacy of bendamustine and rituximab in unfit patients with previously untreated chronic lymphocytic leukemia. Indirect comparison with ibrutinib in a real‐world setting. A GIMEMA‐ERIC and US study
por: Cuneo, Antonio, et al.
Publicado: (2020)

Safety of obinutuzumab alone or combined with chemotherapy for previously untreated or relapsed/refractory chronic lymphocytic leukemia in the phase IIIb GREEN study
por: Leblond, Véronique, et al.
Publicado: (2018)

Prevalence of patients with epilepsy unfit to drive
por: Al Zaid, Esra' H.
Publicado: (2019)

HOW TO TREAT UNFIT AND FRAIL PATIENTS
por: Cook, Gordon
Publicado: (2022)

Efficacy of venetoclax combined with hypomethylating agents in young, and unfit patients with newly diagnosed core binding factor acute myeloid leukemia
por: Zhang, Keyuan, et al.
Publicado: (2023)

Cost-effectiveness of a 12-month fixed-duration venetoclax treatment in combination with obinutuzumab in first-line, unfit chronic lymphocytic leukemia in the United States
por: Chatterjee, Anuja, et al.
Publicado: (2021)

Venetoclax combinations delay the time to deterioration of HRQoL in unfit patients with acute myeloid leukemia
por: Pratz, Keith W., et al.
Publicado: (2022)

Obinutuzumab plus fludarabine and cyclophosphamide in previously untreated, fit patients with chronic lymphocytic leukemia: a subgroup analysis of the GREEN study
por: Bosch, Francesc, et al.
Publicado: (2019)

Chlorambucil plus Rituximab as Front-Line Therapy in Elderly/Unfit Patients Affected by B-Cell Chronic Lymphocytic Leukemia: Results of a Single-Centre Experience
por: Laurenti, Luca, et al.
Publicado: (2013)

INCB84344-201: Ponatinib and steroids in frontline therapy for unfit patients with Ph(+) acute lymphoblastic leukemia
por: Martinelli, Giovanni, et al.
Publicado: (2022)

Glasdegib in combination with low-dose Cytarabine for the outpatient treatment of relapsed or refractory acute myeloid leukemia in unfit patients
por: Zucenka, Andrius, et al.
Publicado: (2021)

Azacitidine vs. Decitabine in Unfit Newly Diagnosed Acute Myeloid Leukemia Patients: Results from the PETHEMA Registry
por: Labrador, Jorge, et al.
Publicado: (2022)

Efficacy and Safety of Metronomic Chemotherapy Versus Palliative Hydroxyurea in Unfit Acute Myeloid Leukemia Patients: A Multicenter, Open-Label Randomized Controlled Trial
por: Pongudom, Saranya, et al.
Publicado: (2020)

Mandatory reporting by physicians of patients potentially unfit to drive
por: Redelmeier, Donald A, et al.
Publicado: (2008)

Dyslipidemia is Associated with Unfit and Overweight-Obese Children and Adolescents
por: Reuter, Cézane Priscila, et al.
Publicado: (2016)

Prenatal Substance Use: Exploring Assumptions of Maternal Unfitness
por: Terplan, Mishka, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_g427a55nuin6ohh5hcdkicl7m9